Abstract 572: Tumor-activated PD1-directed IL-2 increased antigen specific T cells in tumors and demonstrated anti-tumor activity in mice
Ertan Eryilmaz(Arup Group (United States)), Carl Uli Bialucha(Xilio Therapeutics (United States)), Haley Duprey(Xilio Therapeutics (United States)), Kyle P. Smith(Queensland University of Technology), Jacob Taylor(Xilio Therapeutics (United States)), Oleg Yerov(Xilio Therapeutics (United States)), Wilson Guzman(Xilio Therapeutics (United States)), Joseph D. Card(Xilio Therapeutics (United States)), Kurt A. Jenkins(City Of Hope National Medical Center), Magali Pederzoli-Ribeil(Xilio Therapeutics (United States)), Jimit Lakhani(Xilio Therapeutics (United States)), David Crowe(Xilio Therapeutics (United States)), Parker Johnson(Xilio Therapeutics (United States)), Justin Greene(University of Colorado Cancer Center), Caitlin O’Toole(Xilio Therapeutics (United States)), W Scott(Xilio Therapeutics (United States)), Rosa Quiroz(Xilio Therapeutics (United States)), Stephanie Hsiao(Xilio Therapeutics (United States)), Hanumantha Rao Madala(Xilio Therapeutics (United States)), Benjamin Nicholson(Progenra (United States)), Damiano Fantini(Northwestern University), Sallyann Vu(Xilio Therapeutics (United States)), Chelsea Turcotte(Xilio Therapeutics (United States)), Lisa Quinn(Xilio Therapeutics (United States)), Dheeraj S. Tomar(Xilio Therapeutics (United States)), Brendan Whalen(Xilio Therapeutics (United States)), Jijun Dong(Xilio Therapeutics (United States)), Zhen Liu(Peking University), Sean Yang(Vanderbilt University Medical Center), Janice Lee(Harvard University), Kerri Smith(Xilio Therapeutics (United States)), Jennifer O’Neil(Dana-Farber Cancer Institute), Nancy Chan(New York University), Natalia V. Malkova
Cited by 1
Related Papers
Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing
|Nature Communications|2018|2.1k
<i>FBW7</i> mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
|The Journal of Experimental Medicine|2007|660
Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis
|Science|2020|377
Homology-mediated end joining-based targeted integration using CRISPR/Cas9
|Cell Research|2017|350